In vitro 3D microfluidic chip assay. HSC‐3 was embedded in human tumour‐derived matrix along with patients’ serum, cancer and immune cells, which were then loaded with anti‐PD‐L1 and IDO1 inhibitors. Immune cell migration and cancer cell proliferation rates were evaluated. The gene discussed is IDO1; the disease is cancer.